160 related articles for article (PubMed ID: 32994455)
41. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
[TBL] [Abstract][Full Text] [Related]
42. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.
Karpanen TJ; Casey AL; Whitehouse T; Nightingale P; Das I; Elliott TS
Am J Infect Control; 2016 Jan; 44(1):54-60. PubMed ID: 26455868
[TBL] [Abstract][Full Text] [Related]
43. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
44. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
45. Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance.
Jenks M; Craig J; Green W; Hewitt N; Arber M; Sims A
Appl Health Econ Health Policy; 2016 Apr; 14(2):135-49. PubMed ID: 26458938
[TBL] [Abstract][Full Text] [Related]
46. Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years.
Eggimann P; Pagani JL; Dupuis-Lozeron E; Ms BE; Thévenin MJ; Joseph C; Revelly JP; Que YA
Intensive Care Med; 2019 Jun; 45(6):823-833. PubMed ID: 30997542
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
[TBL] [Abstract][Full Text] [Related]
48. Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials.
Timsit JF; Bouadma L; Mimoz O; Parienti JJ; Garrouste-Orgeas M; Alfandari S; Plantefeve G; Bronchard R; Troche G; Gauzit R; Antona M; Canet E; Bohe J; Herrault MC; Schwebel C; Ruckly S; Souweine B; Lucet JC
Am J Respir Crit Care Med; 2013 Nov; 188(10):1232-9. PubMed ID: 24127770
[TBL] [Abstract][Full Text] [Related]
49. Minimising central line-associated bloodstream infection rate in inserting central venous catheters in the adult intensive care units.
Hina HR; McDowell JRS
J Clin Nurs; 2017 Dec; 26(23-24):3962-3973. PubMed ID: 28334482
[TBL] [Abstract][Full Text] [Related]
50. Evaluating central venous catheter care in a pediatric intensive care unit.
Hatler C; Buckwald L; Salas-Allison Z; Murphy-Taylor C
Am J Crit Care; 2009 Nov; 18(6):514-20; quiz 521. PubMed ID: 19880953
[TBL] [Abstract][Full Text] [Related]
51. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine.
Chaiyakunapruk N; Veenstra DL; Lipsky BA; Sullivan SD; Saint S
Clin Infect Dis; 2003 Sep; 37(6):764-71. PubMed ID: 12955636
[TBL] [Abstract][Full Text] [Related]
52. [The Incidences of Catheter Colonization and Central Line-Associated Bloodstream Infection According to Tegaderm vs. Chlorhexidine Gluconate (CHG)-Tegaderm Dressing].
Kim E; Lee H
J Korean Acad Nurs; 2020 Aug; 50(4):541-553. PubMed ID: 32895341
[TBL] [Abstract][Full Text] [Related]
53. Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
Teschner D; Berisha M; Panse J; Schmitt T; Fiegle E; Naendrup JH; Neitz J; Schmidt-Hieber M; Hentrich M; Böll B; Schalk E
Eur J Haematol; 2023 Dec; 111(6):914-921. PubMed ID: 37705250
[TBL] [Abstract][Full Text] [Related]
54. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.
Humar A; Ostromecki A; Direnfeld J; Marshall JC; Lazar N; Houston PC; Boiteau P; Conly JM
Clin Infect Dis; 2000 Oct; 31(4):1001-7. PubMed ID: 11049783
[TBL] [Abstract][Full Text] [Related]
55. Chlorhexidine gluconate transparent dressing does not decrease central line-associated bloodstream infection in critically ill patients: A randomized controlled trial.
Yu K; Lu M; Meng Y; Zhao Y; Li Z
Int J Nurs Pract; 2019 Dec; 25(6):e12776. PubMed ID: 31631496
[TBL] [Abstract][Full Text] [Related]
56. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters.
Dünser MW; Mayr AJ; Hinterberger G; Flörl CL; Ulmer H; Schmid S; Friesenecker B; Lorenz I; Hasibeder WR
Anesth Analg; 2005 Dec; 101(6):1778-1784. PubMed ID: 16301258
[TBL] [Abstract][Full Text] [Related]
57. Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States.
Ye X; Rupnow M; Bastide P; Lafuma A; Ovington L; Jarvis WR
Am J Infect Control; 2011 Oct; 39(8):647-654. PubMed ID: 21641681
[TBL] [Abstract][Full Text] [Related]
58. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
[TBL] [Abstract][Full Text] [Related]
59. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
[TBL] [Abstract][Full Text] [Related]
60. Maintenance antisepsis in reducing the rate of late-onset central venous catheter-related bloodstream infection: A comparison of 0.05% and 1% chlorhexidine.
Kikuchi M; Sato T; Okada S; Abe N; Sato A; Suzuki Y
J Infect Chemother; 2020 Feb; 26(2):188-193. PubMed ID: 31495567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
